Pharma firm Zydussaid it has entered into a licensing pact with China Medical System Holdings Ltd (CMS) for the development and commercialisation of Desidustat, an innovative candidate, in Greater China.
Loading - Please wait
Date posted: Thursday 23 January 2020
Pharma firm Zydussaid it has entered into a licensing pact with China Medical System Holdings Ltd (CMS) for the development and commercialisation of Desidustat, an innovative candidate, in Greater China.